BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19751452)

  • 21. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on the long-acting insulin analogue glargine.
    Thisted H; Johnsen SP; Rungby J
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
    Campbell IW
    Int J Clin Pract; 2005 Oct; 59(10):1218-28. PubMed ID: 16178991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insulin therapy for non-insulin-dependent diabetes: minimal or intensive].
    Drouin P
    Diabetes Metab; 1997 Sep; 23 Suppl 3():36-43. PubMed ID: 9410551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consensus evidence-based guidelines for insulin initiation, optimization and continuation in type 2 diabetes mellitus.
    Shah S; Sharma SK; Singh P; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):49-54. PubMed ID: 25668937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical guidance to insulin management.
    Meneghini L; Artola S; Caputo S; Damci T; Dzida G; Kaiser M; Khunti K; Liebl A; Ligthelm R; Maran A; Orozco-Beltran D; Ross S; Yale JF
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S43-56. PubMed ID: 20394891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telemedicine and diabetes: achievements and prospects.
    Franc S; Daoudi A; Mounier S; Boucherie B; Dardari D; Laroye H; Neraud B; Requeda E; Canipel L; Charpentier G
    Diabetes Metab; 2011 Dec; 37(6):463-76. PubMed ID: 21889388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimising glycaemic control for patients starting insulin therapy.
    Capaldi B
    Nurs Stand; 2007 Jul 11-17; 21(44):49-57; quiz 58. PubMed ID: 17685164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the treatment experience for patients with type 2 diabetes: role of the nurse practitioner.
    Bartol T
    J Am Acad Nurse Pract; 2012 Apr; 24 Suppl 1():270-6. PubMed ID: 22564103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of diabetes in terminal illness related to cancer.
    King EJ; Haboubi H; Evans D; Baker I; Bain SC; Stephens JW
    QJM; 2012 Jan; 105(1):3-9. PubMed ID: 21920998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consensus evidence-based guidelines for in-patient management of hyperglycaemia in non-critical care setting as per Indian clinical practice.
    Gangopadhyay KK; Bantwal G; Talwalkar PG; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):6-15. PubMed ID: 25668932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What has changed in the therapeutic strategy for type 2 diabetes mellitus?].
    Casado PP; Szymaniec J; Conthe P
    Rev Clin Esp; 2010 Sep; 210 Suppl 1():18-25. PubMed ID: 21130912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes.
    Ghosh S; Unnikrishnan AG; Saboo B; Kesavadev J; Aravind SR; Bajaj S; Rajput R; Seshadri K; Verma N; Gupta A; Makkar BM; Saikia M; Kale S; Damodaran S; Dengra A; Eashwar TKM; Maheshwari A; Pendsey S; Phatak SR; Sharma SK; Singh SK; Ramachandran A; Zargar AH; Joshi SR; Sadikot SM
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S507-S521. PubMed ID: 28433618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensification lessons with modern premixes: from clinical trial to clinical practice.
    Guler S; Vaz JA; Ligthelm R
    Diabetes Res Clin Pract; 2008 Sep; 81 Suppl 1():S23-30. PubMed ID: 18684540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.
    Bailey CJ; Aschner P; Del Prato S; LaSalle J; Ji L; Matthaei S;
    Diab Vasc Dis Res; 2013 Sep; 10(5):397-409. PubMed ID: 23711582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breaking down barriers to insulin management in primary care.
    Williams R
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():vii-viii. PubMed ID: 20394892
    [No Abstract]   [Full Text] [Related]  

  • 37. Early use of insulin in the management of type 2 diabetes--the time is now.
    King DE
    South Med J; 2007 Feb; 100(2):127. PubMed ID: 17330676
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of barriers to insulin therapy and approaches to overcoming them.
    Russell-Jones D; Pouwer F; Khunti K
    Diabetes Obes Metab; 2018 Mar; 20(3):488-496. PubMed ID: 29053215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Will I have to be on insulin for the rest of my life?": Introduction.
    Meneghini L
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S1-2. PubMed ID: 20394885
    [No Abstract]   [Full Text] [Related]  

  • 40. Treat early, treat appropriately.
    Liebl A; Rutten G; Abraira C
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S3-10. PubMed ID: 20394889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.